Kiadis updates status of marketing authorization application for ATIR101
June 28, 2019 12:11 ET | Kiadis Pharma N. V.
Kiadis updates status of marketing authorization application for ATIR101 Amsterdam, The Netherlands, June 28, 2019 - Kiadis Pharma N.V. ("Kiadis" or the "Company") (Euronext Amsterdam and...
logo.jpg
Kiadis Pharma N. V.: Kiadis Pharma announces abstracts and presentations for the 60th American Society of Hematology (ASH) Annual Meeting
November 07, 2018 01:00 ET | Kiadis Pharma Netherlands B.V.
                                                                   Kiadis Pharma announces abstracts and presentations for the 60th American Society of Hematology (ASH) Annual Meeting Amsterdam,...
Kiadis Pharma N. V.: Kiadis Pharma raises €23.4 million in a private placement of 2.6 million new shares
March 13, 2018 02:00 ET | Kiadis Pharma Netherlands B.V.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE,...
Kiadis Pharma N. V.: CORRECTION (Includes Disclaimers) Kiadis Pharma launches a private placement of approximately 2.6 million new shares
March 12, 2018 12:57 ET | Kiadis Pharma Netherlands B.V.
Not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, south africa or Any other jurisdiction in which such release,...
Kiadis Pharma N. V.: Kiadis Pharma launches a private placement of approximately 2.6 million new shares
March 12, 2018 12:45 ET | Kiadis Pharma Netherlands B.V.
                                                   Kiadis Pharma launches a private placement of approximately 2.6 million new shares Amsterdam, The Netherlands, March 12, 2018 - Kiadis Pharma...